Related Experiment Video
Updated: Feb 8, 2026

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
Newly developed strategies for improving sensitivity to radiation by targeting signal pathways in cancer therapy
Miao Ding1, Erlong Zhang, Rong He
1Department of Cardiology, Children Hospital, Chongqing Medical University, Chongqing, China.
Abstract:
Inherent and acquired resistance of cancer cells is increasingly recognized as a significant impediment to effective radiation cancer treatment. As important intracellular factors, aberrant tumor transmembrane signal transduction pathways, which include the prosurvival cascades (PI3K/Akt, MAPK/ERK and JAK/STAT) and the proapoptosis pathways (Wnt, p53 and TNF-α/NF-κB), have been proved to be crucial determinants of the probability of cell sensitivity to radiation in malignant lesions. There is increasing evidence that targeting the abnormal pathways that can regulate the activity of the DNA damage response and further influence the response of tumor cells to radiation may be suitable for improving radiation sensitization. Preclinical and clinical evidence suggest that agents targeting aberrant tumor signals can effectively improve the therapeutic effect of ionizing radiation. Therefore, in this review, we discuss the intricate interplay between tumor responses to radiation with the aberrant signal pathways, and the potential druggable targets within the pathways to sensitize tumors without significant collateral damage to normal tissues. The application of novel targeting compounds to manipulate the aberrant signal of tumor cells in clinical treatments is also addressed.
Insights
Cancer cells develop resistance to radiation therapy, hindering treatment effectiveness. Targeting aberrant signaling pathways can improve tumor cell sensitivity to radiation, enhancing cancer treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Radiotherapy
Background:
- Cancer cell resistance to radiation therapy is a major clinical challenge.
- Aberrant tumor transmembrane signal transduction pathways critically influence radiation sensitivity.
- Prosurvival (PI3K/Akt, MAPK/ERK, JAK/STAT) and proapoptosis (Wnt, p53, TNF-α/NF-κB) pathways are key regulators.
Purpose of the Study:
- To review the interplay between tumor radiation response and aberrant signaling pathways.
- To identify potential druggable targets for improving radiation sensitization.
- To discuss the application of novel targeting compounds in clinical settings.
Main Methods:
- Literature review of preclinical and clinical evidence.
- Analysis of aberrant tumor signaling pathways in radiation resistance.
- Identification of therapeutic strategies targeting signal transduction pathways.
Main Results:
- Targeting abnormal signaling pathways can overcome cancer cell resistance to radiation.
- Agents targeting aberrant tumor signals enhance the therapeutic effect of ionizing radiation.
- Modulating DNA damage response pathways influences tumor cell radiosensitivity.
Conclusions:
- Targeting aberrant signaling pathways offers a promising strategy to sensitize tumors to radiation.
- Developing novel compounds to manipulate tumor cell signaling can improve radiation cancer treatment.
- Strategies should aim to sensitize tumors without causing significant collateral damage to normal tissues.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
08:17Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...